Tolerability of combined modality therapy for rectal cancer in elderly patients aged 75 years and older

DN Margalit, HJ Mamon, M Ancukiewicz… - International Journal of …, 2011 - Elsevier
PURPOSE: To determine the rate of treatment deviations during combined modality therapy
for rectal cancer in elderly patients aged 75 years and older. METHODS AND MATERIALS …

Tolerability of combined modality therapy for rectal cancer in elderly patients aged 75 years and older.

DN Margalit, HJ Mamon, M Ancukiewicz… - … Journal of Radiation …, 2011 - europepmc.org
Tolerability of combined modality therapy for rectal cancer in elderly patients aged 75 years
and older. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC …

[引用][C] Tolerability of Combined Modality Therapy for Rectal Cancer in Elderly Patients Aged 75 Years and Older

DN Margalit, HJ Mamon, M Ancukiewicz… - International Journal of …, 2011 - cir.nii.ac.jp
Tolerability of Combined Modality Therapy for Rectal Cancer in Elderly Patients Aged 75
Years and Older | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データを …

Tolerability of combined modality therapy for rectal cancer in elderly patients aged 75 years and older

DN Margalit, HJ Mamon… - … journal of radiation …, 2011 - pubmed.ncbi.nlm.nih.gov
Purpose To determine the rate of treatment deviations during combined modality therapy for
rectal cancer in elderly patients aged 75 years and older. Methods and materials We …

Tolerability of Combined Modality Therapy for Rectal Cancer in Elderly Patients Aged 75 Years and Older

DN Margalit, HJ Mamon, M Ancukiewicz… - International Journal of …, 2011 - redjournal.org
Purpose To determine the rate of treatment deviations during combined modality therapy for
rectal cancer in elderly patients aged 75 years and older. Methods and Materials We …

Tolerability of Combined Modality Therapy for Rectal Cancer in Elderly Patients Aged 75 Years and Older

DN Margalit, HJ Mamon, M Ancukiewicz… - International Journal of …, 2011 - inis.iaea.org
[en] Purpose: To determine the rate of treatment deviations during combined modality
therapy for rectal cancer in elderly patients aged 75 years and older. Methods and Materials …

Tolerability of Combined Modality Therapy for Rectal Cancer in Elderly Patients Aged 75 Years and Older

DN Margalit, HJ Mamon, M Ancukiewicz… - International Journal of …, 2011 - osti.gov
Purpose: To determine the rate of treatment deviations during combined modality therapy for
rectal cancer in elderly patients aged 75 years and older. Methods and Materials: We …

Tolerability of Combined Modality Therapy for Rectal Cancer in Elderly Patients Aged 75 Years and Older

DN Margalit, HJ Mamon, M Ancukiewicz… - International Journal of …, 2011 - infona.pl
To determine the rate of treatment deviations during combined modality therapy for rectal
cancer in elderly patients aged 75 years and older. We reviewed the records of …